NYSEArca - Nasdaq Real Time Price USD

Virtus LifeSci Biotech Products ETF (BBP)

64.03 +1.33 (+2.12%)
As of September 13 at 2:18 PM EDT. Market Open.
Loading Chart for BBP
DELL
  • Previous Close 62.70
  • Open 62.94
  • Bid 63.74 x 900
  • Ask 63.89 x 1300
  • Day's Range 64.02 - 64.03
  • 52 Week Range 45.00 - 65.03
  • Volume 163
  • Avg. Volume 1,979
  • Net Assets 22.49M
  • NAV 64.12
  • PE Ratio (TTM) --
  • Yield 0.00%
  • YTD Daily Total Return 10.22%
  • Beta (5Y Monthly) 0.70
  • Expense Ratio (net) 0.79%

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.

Virtus

Fund Family

Health

Fund Category

22.49M

Net Assets

2014-12-16

Inception Date

Performance Overview: BBP

View More

Trailing returns as of 9/13/2024. Category is Health.

YTD Return

BBP
10.22%
Category
12.21%
 

1-Year Return

BBP
21.89%
Category
16.25%
 

3-Year Return

BBP
7.33%
Category
1.82%
 

People Also Watch

Holdings: BBP

View More

Top 10 Holdings (21.39% of Total Assets)

SymbolCompany% Assets
ALNY
Alnylam Pharmaceuticals, Inc. 2.40%
MIRM
Mirum Pharmaceuticals, Inc. 2.37%
ADMA
ADMA Biologics, Inc. 2.35%
PHAT
Phathom Pharmaceuticals, Inc. 2.21%
KNSA
Kiniksa Pharmaceuticals International, plc 2.09%
TGTX
TG Therapeutics, Inc. 2.05%
BCRX
BioCryst Pharmaceuticals, Inc. 2.04%
IOVA
Iovance Biotherapeutics, Inc. 2.03%
LEGN
Legend Biotech Corporation 1.93%
RARE
Ultragenyx Pharmaceutical Inc. 1.93%

Sector Weightings

SectorBBP
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Related ETF News

View More

Research Reports: BBP

View More
  • Raising target price to $20.00

    XENCOR INC has an Investment Rating of HOLD; a target price of $20.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • Argus Quick Note: Weekly Stock List for 09/09/2024: From Back-to-School into Holiday Shopping

    The back-to-school shopping season has just ended. In a blink, we'll be shopping for the holidays. That's should add up to a lot of shopping - but we'll see how secure consumers are feeling about their finances. Shopping patterns offer great insight into the state of consumers, who are the backbone of the U.S. economy (accounting for two-thirds of GDP). It's still a little early for some of the bigger industry groups to put out their holiday estimates, but we do have some data points to consider. Overall, the National Retail Federation expects retail sales to increase 2.5%-3.5% for the entire year. Stastista expects a 4% increase in holiday sales for 2024 compared to 2023. eMarketer forecasts a healthy 4.8% rise in holiday sales compared to last year. Salesforce predicts a 2% increase in 2024 holiday sales, which is still growing but at a slower pace than the 3% logged last year. In sum, consumer spending growth could be between 2%-5% this holiday period. Meanwhile, Forbes notes the following particulars about this upcoming holiday season: 1) it is shortened, with only 27 days between Thanksgiving and Christmas; 2) past presidential election years have shown a dip in spending leading up to and following the election; and 3) Walmart and Amazon account for roughly 38% of total retail growth, presenting a challenge for other retailers. The following is a list of BUY-rated stocks in Argus' Universe of Coverage. These represent companies that are leaders in the retail industry. Some of these stocks are also in various Argus portfolios.

     
  • Paramount: Improved Skydance Deal Looks Even Better Than We Expected

    Paramount Global operates in three global business segments: TV media, filmed entertainment, and direct to consumer. The TV media business includes television production studios and various broadcast and cable networks, including CBS, 15 owned CBS affiliates, Paramount, Nickelodeon, MTV, BET, and VH1. Filmed entertainment consists multiple film studios, most importantly Paramount Pictures. The film studios produce and distribute movies that they license to movie theaters and other media outlets. Direct to consumer includes multiple streaming platforms, including Paramount+, which now includes Showtime, Pluto TV, and BET+. Much of the content on Paramount’s streaming platforms is created by the production studios housed within the firm’s other two business segments.

    Rating
    Price Target
     
  • Netflix Earnings: Fantastic Period Dampened by Likelihood of Growth Deceleration

    Netflix’s relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with almost 250 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm recently began introducing ad-supported subscription plans, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.

    Rating
    Price Target
     

Related Tickers